These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 28032521)
1. The influence of direct compression powder blend transfer method from the container to the tablet press on product critical quality attributes: a case study. Teżyk M; Jakubowska E; Milczewska K; Milanowski B; Voelkel A; Lulek J Drug Dev Ind Pharm; 2017 Jun; 43(6):911-916. PubMed ID: 28032521 [TBL] [Abstract][Full Text] [Related]
2. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes. Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069 [TBL] [Abstract][Full Text] [Related]
3. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression. Sun WJ; Aburub A; Sun CC J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940 [TBL] [Abstract][Full Text] [Related]
4. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression. Hirschberg C; Sun CC; Rantanen J J Pharm Biomed Anal; 2016 Sep; 128():462-468. PubMed ID: 27368089 [TBL] [Abstract][Full Text] [Related]
5. How do formulation and process parameters impact blend and unit dose uniformity? Further analysis of the product quality research institute blend uniformity working group industry survey. Hancock BC; Garcia-Munoz S J Pharm Sci; 2013 Mar; 102(3):982-6. PubMed ID: 23280670 [TBL] [Abstract][Full Text] [Related]
6. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug. Alyami H; Dahmash E; Bowen J; Mohammed AR PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454 [TBL] [Abstract][Full Text] [Related]
7. Reduction of tablet weight variability by optimizing paddle speed in the forced feeder of a high-speed rotary tablet press. Peeters E; De Beer T; Vervaet C; Remon JP Drug Dev Ind Pharm; 2015 Apr; 41(4):530-9. PubMed ID: 24502268 [TBL] [Abstract][Full Text] [Related]
8. Blend Segregation in Tablets Manufacturing and Its Effect on Drug Content Uniformity-A Review. Jakubowska E; Ciepluch N Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834324 [TBL] [Abstract][Full Text] [Related]
9. Effect of drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer. Kornchankul W; Hamed E; Parikh NH; Sakr A Pharmazie; 2002 Jan; 57(1):49-53. PubMed ID: 11836931 [TBL] [Abstract][Full Text] [Related]
10. Streamlining of the Powder Mixing Process based on a Segregation Test. Römerová S; Dammer O; Zámostný P AAPS PharmSciTech; 2021 Jun; 22(5):190. PubMed ID: 34159445 [TBL] [Abstract][Full Text] [Related]
11. Provoking an end-to-end continuous direct compression line with raw materials prone to segregation. Lakio S; Ervasti T; Tajarobi P; Wikström H; Fransson M; Karttunen AP; Ketolainen J; Folestad S; Abrahmsén-Alami S; Korhonen O Eur J Pharm Sci; 2017 Nov; 109():514-524. PubMed ID: 28899763 [TBL] [Abstract][Full Text] [Related]
12. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression. Chattoraj S; Sun CC J Pharm Sci; 2018 Apr; 107(4):968-974. PubMed ID: 29247737 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the powder behavior and the residence time distribution within a production scale rotary tablet press. Dülle M; Özcoban H; Leopold CS Eur J Pharm Sci; 2018 Dec; 125():205-214. PubMed ID: 30312745 [TBL] [Abstract][Full Text] [Related]
14. In-line monitoring of the drug content of powder mixtures and tablets by near-infrared spectroscopy during the continuous direct compression tableting process. Järvinen K; Hoehe W; Järvinen M; Poutiainen S; Juuti M; Borchert S Eur J Pharm Sci; 2013 Mar; 48(4-5):680-8. PubMed ID: 23313622 [TBL] [Abstract][Full Text] [Related]
15. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating. Kunnath K; Huang Z; Chen L; Zheng K; Davé R Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168 [TBL] [Abstract][Full Text] [Related]
16. Real-time monitoring of pharmaceutical properties of medical tablets during direct tableting process by hybrid tableting process parameter-time profiles. Saito S; Hattori Y; Sakamoto T; Otsuka M Biomed Mater Eng; 2020; 30(5-6):509-524. PubMed ID: 31771033 [TBL] [Abstract][Full Text] [Related]
17. On-Demand Manufacturing of Direct Compressible Tablets: Can Formulation Be Simplified? Azad MA; Osorio JG; Wang A; Klee DM; Eccles ME; Grela E; Sloan R; Hammersmith G; Rapp K; Brancazio D; Myerson AS Pharm Res; 2019 Oct; 36(12):167. PubMed ID: 31650274 [TBL] [Abstract][Full Text] [Related]
18. Segregation of formulated powders in direct compression process and evaluations by small bench-scale testers. Deng T; Sousa LM; Garg V; Bradley MSA Int J Pharm; 2023 Nov; 647():123544. PubMed ID: 37871870 [TBL] [Abstract][Full Text] [Related]
19. Integrating sensors for monitoring blend content in a pharmaceutical continuous manufacturing plant. Panikar S; Li J; Rane V; Gillam S; Callegari G; Kurtyka B; Lee S; Muzzio F Int J Pharm; 2021 Sep; 606():120085. PubMed ID: 33737095 [TBL] [Abstract][Full Text] [Related]
20. Formulation of Direct Compression Zidovudine Tablets to Correlate the SeDeM Diagram Expert System and the Rotary Press Simulator Styl'ONE Results. Nofrerias I; Nardi A; Suñé-Pou M; Suñé-Negre JM; García-Montoya E; Pérez-Lozano P; Miñarro M; Bataille B; Ticó JR AAPS PharmSciTech; 2019 Nov; 21(1):1. PubMed ID: 31712905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]